Howard Larkin
Published: Sunday, October 13, 2019
Richard K Parrish II MD, presenting the Jackson Memorial Lecture Award to Emily Chew MD.
Eating a Mediterranean diet, particularly a lot of fish, may be beneficial for those with early or even intermediate age-related macular degeneration, said Emily Y Chew MD in her Jackson Memorial Lecture to the opening session of AAO 2019 in San Francisco, USA.
Research shows that a diet high in fish can reduce the chances of developing AMD by 65 per cent for patients who also have protective genes, Dr Chew said. In the general AMD population studied, a high fish diet reduced progression of AMD by 31 per cent, while high adherence to a Mediterranean diet reduced progression to late AMD by 25 to 40 per cent.
“It’s never too late to start,” said Dr Chew, of the US National Eye Institute, Bethesda, Maryland, USA.
The findings are based on data from the landmark AREDS and AREDS2 studies, genetic tests, and analysis of patient records and retinal images of patients followed for up to two decades. And while genetic tests have identified genes associated with up to a seven-fold increase in risk of AMD development and progression, the tests have less predictive power than clinical assessments and risk scores, Dr Chew said.
Tags: AMD, diet, AAO 2019
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
Read more...
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Read more...
ESCRS Today 2025: All Eyes on Innovation
Watching out for obstacles and opportunities
Read more...
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Read more...
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Read more...
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Read more...
Supplement: ESCRS Clinical Trends Series: Presbyopia
Read more...
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Read more...
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Read more...
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.
Read more...